Browsing by Subject "Heart Rate"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Open Access
    South African tobacco smoking cessation clinical practice guideline
    (2013) van Zyl-Smit, Richard N; Allwood, Brian; Stickells, David; Symons, Gregory; Abdool-Gaffar, Sabs; Murphy, Kathy; Lalloo, Umesh; Vanker, Aneesa; Sabur, Natasha F; Richards, Guy
    Tobacco smoking (i.e. cigarettes, rolled tobacco, pipes, etc.) is associated with significant health risks, reduced life expectancy and negative personal and societal economic impact. Smokers have an increased risk of cancer (i.e. lung, throat, bladder), chronic obstructive pulmonary disease (COPD), tuberculosis and cardiovascular disease (i.e. stroke, heart attack). Smoking affects unborn babies, children and others exposed to second hand smoke. Stopping or 'quitting' is not easy. Nicotine is highly addictive and smoking is frequently associated with social activities (e.g. drinking, eating) or psychological factors (e.g. work pressure, concerns about body weight, anxiety or depressed mood). The benefits of quitting, however, are almost immediate, with a rapid lowering of blood pressure and heart rate, improved taste and smell, and a longer-term reduction in risk of cancer, heart attack and COPD. Successful quitting requires attention to both the factors surrounding why an individual smokes (e.g. stress, depression, habit, etc.) and the symptoms associated with nicotine withdrawal. Many smokers are not ready or willing to quit and require frequent motivational input outlining the benefits that would accrue. In addition to an evaluation of nicotine dependence, co-existent medical or psychiatric conditions and barriers to quitting should be identified. A tailored approach encompassing psychological and social support, in addition to appropriate medication to reduce nicotine withdrawal, is likely to provide the best chance of success. Relapse is not uncommon and reasons for failure should be addressed in a positive manner and further attempts initiated when the individual is ready. Key steps in smoking cessation include: (i) identifying all smokers, alerting them to the harms of smoking and benefits of quitting; (ii) assessing readiness to initiate an attempt to quit; (iii) assessing the physical and psychological dependence to nicotine and smoking; (iv) determining the best combination of counselling/support and pharmacological therapy; (v) setting a quit date and provide suitable resources and support; (vi) frequent follow-up as often as possible via text/telephone or in person; (vii) monitoring for side-effects, relapse and on-going cessation; and (viii) if relapse occurs, providing the necessary support and encourage a further attempt when appropriate.
  • Thumbnail Image
    Item
    Open Access
    The effect of carbohydrate ingestion on performance during a simulated soccer match
    (2013) Goedecke, Julia; White, Nicholas; Chicktay, Waheed; Mahomed, Hafsa; Durandt, Justin; Lambert, Michael
    Aim: This study investigated how performance was affected after soccer players, in a postprandial state, ingested a 7% carbohydrate (CHO) solution compared to a placebo (0% CHO) during a simulated soccer match. Methods: Using a double-blind placebo-controlled design, 22 trained male league soccer players (age: 24 ± 7 years, wt: 73.4 ± 12.0 kg, VO2max: 51.8 ± 4.3 mL O2/kg/min) completed two trials, separated by 7 days, during which they ingested, in random order, 700 mL of either a 7% CHO or placebo drink during a simulated soccer match. Ratings of perceived exertion (RPE), agility, timed and run to fatigue were measured during the trials. Results: Change in agility times was not altered by CHO vs. placebo ingestion (0.57 ± 1.48 vs. 0.66 ± 1.00, p = 0.81). Timed runs to fatigue were 381 ± 267 s vs. 294 ± 159 s for the CHO and placebo drinks, respectively (p = 0.11). Body mass modified the relationship between time to fatigue and drink ingestion (p = 0.02 for drink × body mass), such that lower body mass was associated with increased time to fatigue when the players ingested CHO, but not placebo. RPE values for the final stage of the simulated soccer match were 8.5 ± 1.7 and 8.6 ± 1.5 for the CHO and placebo drinks respectively (p = 0.87). Conclusions: The group data showed that the 7% CHO solution (49 g CHO) did not significantly improve performance during a simulated soccer match in league soccer players who had normal pre-match nutrition. However, when adjusting for body mass, increasing CHO intake was associated with improved time to fatigue during the simulated soccer match.